Splenic vein thrombosis screening: Difference between revisions

Jump to navigation Jump to search
 
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}} ; {{AE}} {{Vbe}}
{{CMG}} ; {{AE}} {{Vbe}}
==Overview==
==Overview==
There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]].  However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein]] [[thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]]. <ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref>
There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]].  However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows the initiation of [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein]] [[thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]].


== Screening==
== Screening==
There is insufficient [[evidence]] to [[Recommended Daily Allowance|recommend]] routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]].  However, routine [[Screening (medicine)|screening]] of [[portal]] and [[splenic vein thrombosis]] after elective splenectomy is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]]. <ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref>
There is insufficient [[evidence]] to [[Recommended Daily Allowance|recommend]] routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]].  However, routine [[Screening (medicine)|screening]] of [[portal]] and [[splenic vein thrombosis]] after elective [[Splenectomy|splenectom]]<nowiki/>y is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein thrombosis]] is particularly high among [[patients]] operated on for [[lymphoma]] or with [[splenomegaly]].<ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref><ref name="pmid26080307">{{cite journal| author=Valla D| title=Splanchnic Vein Thrombosis. | journal=Semin Thromb Hemost | year= 2015 | volume= 41 | issue= 5 | pages= 494-502 | pmid=26080307 | doi=10.1055/s-0035-1550439 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26080307  }}</ref><ref name="pmid29211374">{{cite journal| author=Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M et al.| title=[Splanchnic vein thrombosis]. | journal=Rev Med Suisse | year= 2017 | volume= 13 | issue= 586 | pages= 2138-2143 | pmid=29211374 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211374  }}</ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 16:02, 1 March 2018

Splenic vein thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenic vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Splenic vein thrombosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Splenic vein thrombosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Splenic vein thrombosis screening

CDC on Splenic vein thrombosis screening

Splenic vein thrombosis screening in the news

Blogs on Splenic vein thrombosis screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Splenic vein thrombosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows the initiation of anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.

Screening

There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.[1][2][3]

References

  1. Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O (2017). "[Routine screening of splenic or portal vein thrombosis after splenectomy]". Rev Med Interne (in French). 38 (1): 3–7. doi:10.1016/j.revmed.2016.08.003. PMID 27639911.
  2. Valla D (2015). "Splanchnic Vein Thrombosis". Semin Thromb Hemost. 41 (5): 494–502. doi:10.1055/s-0035-1550439. PMID 26080307.
  3. Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). "[Splanchnic vein thrombosis]". Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.